Clomethiazole acute stroke study (CLASS): Results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients

Stroke

Volumn 30, Issue 1, 1999, Pages 21-28

  Wahlgren, N G ^a   Ranasinha, K W ^b   Rosolacci, T ^c   Franke, C L ^d   Van Erven, P M M ^e   Ashwood, T ^f   Claesson, L ^f  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b EPSOM GENERAL HOSPITAL   (United Kingdom)

^c CENTRE HOSPITALIER   (France)

^d Sittard Geleen Heerlen   (Netherlands)

^e Ignatius Hospital   (Netherlands)

^f Astra Arcus AB   (Sweden)

Author keywords

Cerebral ischemia; Clinical trials; Clomethiazole; Efficacy; Neuroprotection

Indexed keywords

CLOMETHIAZOLE;

ADULT; AGED; AGITATION; ARTICLE; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCORING SYSTEM; SEDATION; SIDE EFFECT; STROKE; TREATMENT OUTCOME; VOMITING;

EID: 0032953495     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.1.21     Document Type: Article

References (20)

1. Sydserff SG, Cross AJ, Green AR. The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat. Neurodegeneration. 1995;4:323-328.
2. Sydserff SG, Cross AJ, West KJ, Green AR. The effect of chlormethiazole on ischaemic neuronal damage in a model of transient focal ischaemia. Br J Pharmacol. 1995;114:1631-1635.
3. Snape MF, Baldwin HA, Cross AJ, Green AR. The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience. 1993;53:837-844.
4. Marshall JWB, Cross AJ, Murray TK, Ridley RM. Clomethiazole treatment ameliorates the motor disability produced by focal cerebral ischaemia in a non-human primate species. Stroke. 1998;29:330. Abstract P164.
5. Cross AJ, Jones JA, Baldwin MA, Green AR. Neuroprotective activity of Clomethiazole following transient forebrain ischemia in the gerbil. Br J Pharmacol. 1991;104:406-411.
6. Cross AJ, Jones JA, Snares M, Jostell K-G, Bredberg U, Green AR. The protective action of chlormethiazole against ischaemia-induced neurogeneration in gerbils when infused at doses having little sedative or anticonvulsant activity. Br J Pharmacol. 1995;114:1625-1630.
7. A receptor complex in rat brain. Br J Pharmacol. 1989;98:284-290.
8. Hales TB, Lambert JJ. Modulation of GABAA and glycine receptors by chlormethiazole. Eur J Pharmacol. 1992;210:239-246.
9. Moody EJ, Skolnick P. Clomethiazole: neurochemical actions at the gamma-aminobutyric acid receptor complex. Br J Pharmacol. 1989;164: 153-158.
10. Wester P, Strand T, Wahlgren NG, Ashwood T, Osswald G. An open study of clomethiazole in patients with acute cerebral infarction. Cerebrovasc Dis. 1998;8:188-190.
11. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke, I: results in (he total study population. Stroke. 1987;18: 691-699.
12. Bamford J, Sandercock P. Dennis M, Bum J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
13. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med. 1965;14:61-65.
14. Geller NL, Pocock SJ. Interim analyses in randomized clinical trials: ramifications and guidelines for practioners. Biometrics. 1987;43: 213-223.
15. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med. 1995;333:1581-1587.
16. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH. Hennerici M, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
17. Heiss W-D, Huber M, Fink GR, Herholz K, Pietrzyk U, Wagner R, Wienhard K. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab. 1992;12:193-203.
18. Marchai G, Beaudouin V, Rioux P, De La Sayette V, Le Doze F, Viader F, Derlon M, Baron JC. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke. 1996;27:599-606.
19. Baird AE, Benfield A, Schlaug G, Siewert B, Lovblad KO, Edelman RR, Warach S. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 1997;41:581-589.
20. Lindgren A, Norrving B, Rudling O, Johansson B. Comparison of clinical and neurological findings in first-ever stroke: a population-based study. Stroke. 1994;25:1371-1377.